ACT Capital Partners, L.P.
Sector Allocation
- Healthcare50.7%$76.8M
- Energy20.3%$30.7M
- Technology12.7%$19.3M
- Consumer Discretionary10.4%$15.8M
- Materials3.0%$4.5M
- Communication Services1.5%$2.3M
- Financials0.9%$1.3M
- Other0.3%$384,650
- Industrials0.2%$270,475
- Consumer Staples0.1%$222,900
Largest positions — Q3 2026
CVX
$15.3MKRYS
$14.0MTGTX
$13.2MXOM.R34088
$12.8MAMZN
$10.6MABVX
$8.4MVKTX
$7.2MSKHY
$6.4MARWR
$6.2MNKTR
$5.5MTSLA
$5.3MCELC
$4.7MMU
$3.7MNUVB
$3.2MPVLA
$3.1MET
$2.6MBE
$2.5MASTS
$2.3MFCX
$2.3MCCJ
$2.2M
Top 20 stock positions. Options are left out: 13F reports them at the underlying's value.
13fpro.ai/research/fund/act-capital-partners-l-p-1875197
ACT Capital Partners, L.P. 13F holdings — Q3 2026
$154.0M portfolio · 58 holdings · Q3 2026 13F · top 10 are 66% of the stock portfolio
Includes $2.4M of put/call options ($0 puts, $2.4M calls), which 13F rules report at the value of the underlying shares, not the premium at risk. Stocks alone: $151.6M. Weights use the stock portfolio.
$15.3M
10.1% of stocks
—This quarter-2.9%Since filed1+ qtrsHeld$14.0M
9.2% of stocks
—This quarter+5.0%Since filed1+ qtrsHeld$13.2M
8.7% of stocks
—This quarter+8.4%Since filed1+ qtrsHeld$12.8M
8.4% of stocks
—This quarter—Since filed1+ qtrsHeld$10.6M
7.0% of stocks
—This quarter-0.7%Since filed1+ qtrsHeld$8.4M
5.5% of stocks
—This quarter-5.9%Since filed1+ qtrsHeld$7.2M
4.7% of stocks
—This quarter-3.7%Since filed1+ qtrsHeld$6.4M
4.2% of stocks
—This quarter-6.4%Since filed1+ qtrsHeld$6.2M
4.1% of stocks
—This quarter-24.9%Since filed1+ qtrsHeld$5.5M
3.6% of stocks
—This quarter-12.7%Since filed1+ qtrsHeld
All holdings — ACT Capital Partners, L.P. (Q3 2026)
58 disclosed positions from the Form 13F-HR on SEC EDGAR, with quarter-over-quarter share changes. Largest by value first; the ten above are not repeated.
| # | Company | Held | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 11 | Tesla, Inc. | Consumer Discretionary | $5.3M | 3.5% | 15K | — | 1+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 12 | Celcuity Inc. | Healthcare | $4.7M | 3.1% | 59K | — | 1+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 13 | MICRON TECHNOLOGY INC | Technology | $3.7M | 2.5% | 3,500 | — | 1+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 14 | Nuvation Bio Inc. | Healthcare | $3.2M | 2.1% | 580K | — | 1+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 15 | PALVELLA THERAPEUTICS, INC. | Healthcare | $3.1M | 2.0% | 23K | — | 1+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 16 | Energy Transfer LP | Energy | $2.6M | 1.7% | 133K | — | 1+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 17 | Bloom Energy Corp | Technology | $2.5M | 1.6% | 9,000 | — | 1+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 18 | AST SpaceMobile, Inc. | Communication Services | $2.3M | 1.5% | 39K | — | 1+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 19 | FREEPORT-MCMORAN INC | Materials | $2.3M | 1.5% | 33K | — | 1+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 20 | CAMECO CORP | Materials | $2.2M | 1.4% | 25K | — | 1+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 21 | Mineralys Therapeutics, Inc. | Healthcare | $2.2M | 1.4% | 87K | — | 1+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 22 | AXT INC | Technology | $2.0M | 1.3% | 25K | — | 1+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 23 | Helus Pharma Inc. | Healthcare | $1.7M | 1.1% | 135K | — | 1+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 24 | Candel Therapeutics, Inc. | Healthcare | $1.6M | 1.0% | 151K | — | 1+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 25 | SK hynix Inc. | Technology | $1.3M | — | 7,000 | — | — | — | 13F | |
| 26 | $AMBA | AMBARELLA INC | Technology | $1.2M | 0.8% | 17K | — | |||
| 27 | $AAOI | APPLIED OPTOELECTRONICS, INC. | Technology | $1.2M | 0.8% | 12K | — | |||
| 28 | $TSLA CALL | Tesla, Inc. | Consumer Discretionary | $1.1M | — | 3,000 | — | |||
| 29 | $GBTC | Grayscale Bitcoin Trust ETF | Financials | $995K | 0.7% | 15K | — | |||
| 30 | $KURA | Kura Oncology, Inc. | Healthcare | $981K | 0.7% | 92K | — | |||
| 31 | $SGMT | Sagimet Biosciences Inc. | Healthcare | $593K | 0.4% | 60K | — | |||
| 32 | $CMPS | COMPASS Pathways plc | Healthcare | $567K | 0.4% | 46K | — | |||
| 33 | $VIR | Vir Biotechnology, Inc. | Healthcare | $559K | 0.4% | 50K | — | |||
| 34 | $ON | ON SEMICONDUCTOR CORP | Technology | $553K | 0.4% | 7,200 | — | |||
| 35 | $ACOG | Alpha Cognition Inc. | Healthcare | $464K | 0.3% | 52K | — | |||
| 36 | $CBRS | Cerebras Systems Inc. | Technology | $444K | 0.3% | 2,500 | — | |||
| 37 | $ANL | Adlai Nortye Group Ltd. | Healthcare | $430K | 0.3% | 24K | — | |||
| 38 | $PALI | PALISADE BIO, INC. | Healthcare | $415K | 0.3% | 308K | — | |||
| 39 | $RGNX | REGENXBIO Inc. | Healthcare | $395K | 0.3% | 53K | — | |||
| 40 | $NOK | NOKIA CORP | Technology | $355K | 0.2% | 35K | — | |||
| 41 | $PATH | UiPath, Inc. | Technology | $347K | 0.2% | 27K | — | |||
| 42 | $KZIA | KAZIA THERAPEUTICS LTD | Healthcare | $336K | 0.2% | 35K | — | |||
| 43 | $CRVS | Corvus Pharmaceuticals, Inc. | Healthcare | $311K | 0.2% | 27K | — | |||
| 44 | $ARCT | Arcturus Therapeutics Holdings Inc. | Healthcare | $308K | 0.2% | 23K | — | |||
| 45 | $ONDS | Ondas Inc. | Technology | $275K | 0.2% | 38K | — | |||
| 46 | $KYTX | Kyverna Therapeutics, Inc. | Healthcare | $272K | 0.2% | 40K | — | |||
| 47 | $KEEL | Keel Infrastructure Corp. | Financials | $263K | 0.2% | 75K | — | |||
| 48 | — | CHURCHILL CAP CORP XI - CL A ORD SHS | — | $261K | 0.2% | 23K | — | |||
| 49 | $APC | ARKO Petroleum Corp. | Consumer Staples | $223K | 0.1% | 15K | — | |||
| 50 | $XE | X-Energy, Inc. | Industrials | $177K | 0.1% | 13K | — | |||
| 51 | $CBIO | CRESCENT BIOPHARMA, INC. | Healthcare | $168K | 0.1% | 12K | — | |||
| 52 | $TNGX | Tango Therapeutics, Inc. | Healthcare | $150K | 0.1% | 6,000 | — | |||
| 53 | — | CAPSTONE ENERGY PLUS, INC. - COM | — | $123K | 0.1% | 28K | — | |||
| 54 | $LSPD | Lightspeed Commerce Inc. | Technology | $122K | 0.1% | 13K | — | |||
| 55 | $SPCX | SPACE EXPLORATION TECHNOLOGIES CORP | Technology | $121K | 0.1% | 800 | — | |||
| 56 | $NKLR | Terra Innovatum Global N.V. | Industrials | $93K | 0.1% | 28K | — | |||
| 57 | $SSYS | STRATASYS LTD. | Technology | $83K | 0.1% | 10K | — | |||
| 58 | $BTC | Grayscale Bitcoin Mini Trust ETF | Financials | $67K | 0.0% | 1,800 | — |
Is it too late to follow ACT Capital Partners, L.P.?
Q3 2026 13F filed with the SEC on Nov 6, 2026. Prices are closing prices as of Nov 19, 2026.
Average quality of ACT Capital Partners, L.P.'s top 20 holdings: 60/100 (our AI quality score, weighted by position size; 14 of the 20 are scored)
Top 10 since filing
-2.4%
Value-weighted move of the 10 largest stock positions
Turnover
—
Last quarter
Top 10 weight
66%
Share of the stock portfolio in its 10 largest positions
Held 4+ quarters
0%
Share of portfolio value in positions held a year or more
Highest-quality names it owns(among its 100 largest positions)
The 8 highest-scoring companies in this portfolio are a Pro feature.
How these are measured
- Moves since the quarter-end and since the filing date use our own daily closing prices, from the close on (or just before) each date to the latest close.
- Turnover is the lesser of shares bought or sold in a quarter, valued at the quarter-end prices in the 13F, divided by the average of the two quarters' stock portfolio values.
- Quarters held and add/trim streaks count back only through quarters whose filed holdings add up to the filing's own cover-page total (back to Q3 2026 for this fund). A change counts as an add or a trim when the split-adjusted share count moves by more than 1%.
- Estimate, not the fund's reported cost. For each quarter in the current holding period in which the fund's share count rose (split-adjusted), we take that quarter's average daily close and weight it by the shares added; sales do not change an average cost. Quarters where the stock's price history and the 13F's own implied price disagree by more than 2x are left out.
- Put and call option rows report the value of the underlying shares, not a position the fund paid for, so they are left out of all of the above.
Portfolio Overview
ACT Capital Partners, L.P. disclosed 58 positions worth $154.0M in its Form 13F-HR for Q3 2026 — $151.6M in common stock plus $2.4M of put/call option positions (reported at underlying notional value, not premium at risk), led by $CVX (CHEVRON CORP) at 10.1% of the equity portfolio, followed by $KRYS and $TGTX. During the quarter the fund opened 58 new positions and exited 0 — including a new stake in $CVX. The portfolio is most concentrated in Healthcare (50.7% of disclosed assets). All figures are sourced directly from ACT Capital Partners, L.P.’s Form 13F-HR filing with the SEC under CIK 1875197.
Funds like this
managers whose biggest positions overlap ACT Capital Partners, L.P.'sBrowse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
AI-Powered Hedge Fund Analysis: ACT Capital Partners, L.P.
13F Pro is an AI hedge fund tracker and stock research platform. For ACT Capital Partners, L.P. (SEC CIK: 1875197), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in ACT Capital Partners, L.P.'s portfolio is scored on an AI quality ranking built from its SEC filings (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.